XML 56 R45.htm IDEA: XBRL DOCUMENT
v3.24.2

Business Segments and Geographic Information (Tables) | 9 Months Ended
--- | ---
Jun. 29, 2024
Segment Reporting [Abstract] |
Segment Information | egment information is as follows:
| Three Months Ended |  | Nine Months Ended
| June 29, 2024 |  | July 1, 2023 |  | June 29, 2024 |  | July 1, 2023
Total revenues: |  |  |  |  |  |  |
Diagnostics | $ | 440.8 |  |  | $ | 439.7 |  |  | $ | 1,338.7 |  |  | $ | 1,463.6 |
Breast Health | 385.0 |  |  | 360.3 |  |  | 1,147.3 |  |  | 1,079.9 |
GYN Surgical | 166.6 |  |  | 157.3 |  |  | 484.8 |  |  | 456.2 |
Skeletal Health | 19.0 |  |  | 27.1 |  |  | 71.5 |  |  | 85.4 |
| $ | 1,011.4 |  |  | $ | 984.4 |  |  | $ | 3,042.3 |  |  | $ | 3,085.1 |
Income from operations: |  |  |  |  |  |  |
Diagnostics | $ | 89.7 |  |  | $ | (113.5) |  |  | $ | 210.1 |  |  | $ | 142.8 |
Breast Health | 102.4 |  |  | 63.3 |  |  | 296.2 |  |  | 233.7 |
GYN Surgical | 56.7 |  |  | 48.5 |  |  | 144.3 |  |  | 149.6 |
Skeletal Health | (4.8) |  |  | 3.1 |  |  | 2.0 |  |  | 9.8 |
| $ | 244.0 |  |  | $ | 1.4 |  |  | $ | 652.6 |  |  | $ | 535.9 |
Depreciation and amortization: |  |  |  |  |  |  |
Diagnostics | $ | 51.0 |  |  | $ | 56.8 |  |  | $ | 168.3 |  |  | $ | 172.9 |
Breast Health | 9.3 |  |  | 12.2 |  |  | 29.6 |  |  | 38.7 |
GYN Surgical | 11.9 |  |  | 11.9 |  |  | 36.1 |  |  | 35.8 |
Skeletal Health | 0.1 |  |  | 0.3 |  |  | 0.4 |  |  | 0.5 |
| $ | 72.3 |  |  | $ | 81.2 |  |  | $ | 234.4 |  |  | $ | 247.9 |
Capital expenditures: |  |  |  |  |  |  |
Diagnostics | $ | 17.7 |  |  | $ | 22.6 |  |  | $ | 61.7 |  |  | $ | 58.7 |
Breast Health | 10.4 |  |  | 8.0 |  |  | 25.1 |  |  | 22.0 |
GYN Surgical | 4.8 |  |  | 4.5 |  |  | 11.5 |  |  | 11.2 |
Skeletal Health | 0.7 |  |  | — |  |  | 1.1 |  |  | 0.2 |
Corporate | 0.3 |  |  | 1.4 |  |  | 0.5 |  |  | 5.6 |
| $ | 33.9 |  |  | $ | 36.5 |  |  | $ | 99.9 |  |  | $ | 97.7 |
| June 29, 2024 |  | September 30, 2023
Identifiable assets: |  |  |
Diagnostics | $ | 2,476.3 |  |  | $ | 2,596.4 |
Breast Health | 1,217.6 |  |  | 1,170.1 |
GYN Surgical | 1,429.8 |  |  | 1,455.4 |
Skeletal Health | 35.6 |  |  | 33.7 |
Corporate | 3,730.8 |  |  | 3,883.7 |
| $ | 8,890.1 |  |  | $ | 9,139.3 |
Revenues by Geography | Revenues by geography as a percentage of total revenues were as follows:
| Three Months Ended |  | Nine Months Ended
| June 29, 2024 |  | July 1, 2023 |  | June 29, 2024 |  | July 1, 2023
United States | 75.7 | % |  | 76.2 | % |  | 74.9 | % |  | 75.9 | %
Europe | 12.6 | % |  | 13.1 | % |  | 13.4 | % |  | 13.9 | %
Asia-Pacific | 6.4 | % |  | 6.4 | % |  | 6.4 | % |  | 6.2 | %
Rest of World | 5.3 | % |  | 4.3 | % |  | 5.3 | % |  | 4.0 | %
| 100.0 | % |  | 100.0 | % |  | 100.0 | % |  | 100.0 | %

X
- Definition Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration